NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
07/12/2024
Back to search
Official data from USPTO
CELLTEX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
48
Latest update
07/12/2024
Trademark type
Word
Nice classes
44
Filing date
08/08/2011
Registration date
06/10/2014
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/12/2024
Last transaction
07/12/2024
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
12/04/2011
First use in commerce
12/04/2011
Drawing code
4
Owner type
03
Owner location
Houston, TX, US
Examiner
SMITH, BRIDGETT G
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
C. C. (pessoa física)
Representatives
Margaret A. Boulware BOULWARE & VALOIR, PLLC
Technical classification
Nice Classes
Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 44
Tissue bank
Publications
History of USPTO decisions and trademark events.
48 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
07/12/2024
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
07/12/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07/12/2024
E89R
TEAS SECTION 8 & 9 RECEIVED
04/15/2024
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
06/10/2023
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
08/08/2019
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
08/08/2019
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/08/2019
E815
TEAS SECTION 8 & 15 RECEIVED
06/25/2019
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
07/11/2014
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07/11/2014
ES7R
TEAS SECTION 7 REQUEST RECEIVED
07/03/2014
R.PR
REGISTERED-PRINCIPAL REGISTER
06/10/2014
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE MAILED
05/06/2014
REGV
LAW OFFICE REGISTRATION REVIEW COMPLETED
05/05/2014
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
05/05/2014
SUPC
STATEMENT OF USE PROCESSING COMPLETE
04/19/2014
IUAF
USE AMENDMENT FILED
04/10/2014
EISU
TEAS STATEMENT OF USE RECEIVED
04/10/2014
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
10/16/2013
EX3G
SOU EXTENSION 3 GRANTED
10/15/2013
EXT3
SOU EXTENSION 3 FILED
10/10/2013
EEXT
SOU TEAS EXTENSION RECEIVED
10/10/2013
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
05/17/2013
EX2G
SOU EXTENSION 2 GRANTED
05/16/2013
NREV
NOTICE OF REVIVAL - MAILED
04/17/2013
TPEX
SOU EXTENSION RECEIVED WITH TEAS PETITION
04/17/2013
PETG
PETITION TO REVIVE-GRANTED
04/17/2013
PROA
TEAS PETITION TO REVIVE RECEIVED
04/17/2013
EXT2
SOU EXTENSION 2 FILED
04/10/2013
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
10/12/2012
EX1G
SOU EXTENSION 1 GRANTED
10/11/2012
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
10/11/2012
EXT1
SOU EXTENSION 1 FILED
10/10/2012
EEXT
SOU TEAS EXTENSION RECEIVED
10/10/2012
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
04/10/2012
PUBO
PUBLISHED FOR OPPOSITION
02/14/2012
NPUB
NOTICE OF PUBLICATION
01/25/2012
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
01/07/2012
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/04/2012
CNEA
EXAMINER'S AMENDMENT MAILED
12/07/2011
XAEC
EXAMINER'S AMENDMENT ENTERED
12/07/2011
ALIE
ASSIGNED TO LIE
12/07/2011
CNEA
EXAMINERS AMENDMENT -WRITTEN
12/07/2011
DOCK
ASSIGNED TO EXAMINER
11/30/2011
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/11/2011
NWAP
NEW APPLICATION ENTERED
08/11/2011
Continuous trademark protection
Get notified about every new filing that threatens CELLTEX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.